- Home
- NMRA vs WSBF Comparison
NMRA vs WSBF Comparison
Compare NMRA & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- WSBF
- Stock Information
- Founded
- NMRA 2019
- WSBF 1921
- Country
- NMRA United States
- WSBF United States
- Employees
- NMRA N/A
- WSBF N/A
- Industry
- NMRA
- WSBF Savings Institutions
- Sector
- NMRA
- WSBF Finance
- Exchange
- NMRA Nasdaq
- WSBF Nasdaq
- Market Cap
- NMRA 121.0M
- WSBF 261.3M
- IPO Year
- NMRA 2023
- WSBF N/A
- Fundamental
- Price
- NMRA $0.84
- WSBF $14.18
- Analyst Decision
- NMRA Buy
- WSBF
- Analyst Count
- NMRA 8
- WSBF 0
- Target Price
- NMRA $9.29
- WSBF N/A
- AVG Volume (30 Days)
- NMRA 1.4M
- WSBF 51.1K
- Earning Date
- NMRA 08-05-2025
- WSBF 07-24-2025
- Dividend Yield
- NMRA N/A
- WSBF 4.23%
- EPS Growth
- NMRA N/A
- WSBF 95.86
- EPS
- NMRA N/A
- WSBF 1.02
- Revenue
- NMRA N/A
- WSBF $133,551,000.00
- Revenue This Year
- NMRA N/A
- WSBF N/A
- Revenue Next Year
- NMRA N/A
- WSBF N/A
- P/E Ratio
- NMRA N/A
- WSBF $13.88
- Revenue Growth
- NMRA N/A
- WSBF 1.81
- 52 Week Low
- NMRA $0.61
- WSBF $11.61
- 52 Week High
- NMRA $17.19
- WSBF $16.86
- Technical
- Relative Strength Index (RSI)
- NMRA 50.68
- WSBF 69.86
- Support Level
- NMRA $0.72
- WSBF $13.60
- Resistance Level
- NMRA $0.84
- WSBF $14.21
- Average True Range (ATR)
- NMRA 0.07
- WSBF 0.25
- MACD
- NMRA -0.01
- WSBF 0.03
- Stochastic Oscillator
- NMRA 52.94
- WSBF 86.61
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.